Business Description
United Health Products Inc
NAICS : 339112
SIC : 3842
ISIN : US91059D1000
Total Employee Number:
2Description
United Health Products Inc develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. Its gauze product, CelluSTAT, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. The company are in the process of seeking regulatory approval to sells hemostatic gauze product line into the U.S. Class III and European CE Mark human surgical markets. The company operates as a single operating segment, focusing on the development and commercialization of medical devices, particularly its patented hemostatic gauze, CelluSTAT.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -16.84 | |||||
Debt-to-Equity | -0.49 | |||||
Debt-to-EBITDA | -1.69 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -12.6 | |||||
3-Year FCF Growth Rate | -18.6 | |||||
3-Year Book Growth Rate | -18.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.25 | |||||
9-Day RSI | 51.31 | |||||
14-Day RSI | 48.81 | |||||
3-1 Month Momentum % | -11.27 | |||||
6-1 Month Momentum % | -10 | |||||
12-1 Month Momentum % | -36.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -6.54 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -858.32 | |||||
ROIC % | -63.86 | |||||
3-Year ROIIC % | 29.1 | |||||
ROC (Joel Greenblatt) % | -5359.65 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | 48.8 | |||||
PEG Ratio | 1.18 | |||||
EV-to-EBIT | -12.09 | |||||
EV-to-EBITDA | -12.1 | |||||
EV-to-FCF | -14.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.63 | |||||
Earnings Yield (Greenblatt) % | -8.27 | |||||
FCF Yield % | -7.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:UEEC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
United Health Products Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | -1.8168 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.37 | ||
| Volatility % | 68.78 | ||
| 14-Day RSI | 48.81 | ||
| 14-Day ATR ($) | 0.007286 | ||
| 20-Day SMA ($) | 0.049247 | ||
| 12-1 Month Momentum % | -36.86 | ||
| 52-Week Range ($) | 0.03324 - 0.12 | ||
| Shares Outstanding (Mil) | 260.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
United Health Products Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
United Health Products Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 102 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 11 days | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.07 (+8.83%) | ||
| Annual report for 2025 | 2026-04-15 | 0.06 (-0.54%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.06 (+20.19%) | ||
| United Health Products Life Sciences Virtual Investor Forum | 2025-09-18 10:30 | 0.08 (+18.33%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 0.09 (-1.56%) | ||
| First quarter earnings results for 2025 | 2025-05-05 | 0.25 (+0.16%) | ||
| Annual report for 2024 | 2025-03-28 | 0.24 (-6.54%) | ||
| Third quarter earnings results for 2024 | 2024-11-12 | 0.10 (+10.89%) |
Show
Entries
United Health Products Inc Frequently Asked Questions
What is United Health Products Inc(UEEC)'s stock price today?
The current price of UEEC is $0.05. The 52 week high of UEEC is $0.12 and 52 week low is $0.03.
When is next earnings date of United Health Products Inc(UEEC)?
The next earnings date of United Health Products Inc(UEEC) is 2026-08-14 Est..
Does United Health Products Inc(UEEC) pay dividends? If so, how much?
United Health Products Inc(UEEC) does not pay dividend.
Guru Commentaries on OTCPK:UEEC
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| United Health Products Provides Corporate Update and Announces Equity Financing | 2021-06-28 |
Articles on United Health Products Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers